ArticleThe American journal of pathology2018

Hepatocyte-Derived Lipocalin 2 Is a Potential Serum Biomarker Reflecting Tumor Burden in Hepatoblastoma.

Laura Molina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.